Janux Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-1.224; its P/E ratio is -38.47; Janux Therapeutics Inc is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.46M	$ 2.52M	$ 1.06M	-	$ 2.85M
Gross Profit	$ 2.46M	$ 2.52M	$ 1.06M	-	-
EBIT	$ -8.93M	$ -11.57M	$ -17.51M	$ -20.28M	$ -18.27M
EBITDA	$ -6.10M	-	$ -18.88M	$ -21.51M	$ -19.16M
Net Income Common Stockholders	$ -11.76M	$ -11.57M	$ -17.51M	$ -17.46M	$ -16.07M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 344.03M	$ 349.71M	$ 303.29M	$ 316.88M	$ 327.02M
Total Assets	$ 380.41M	$ 386.85M	$ 341.50M	$ 352.96M	$ 364.01M
Total Debt	$ 24.54M	$ 24.89M	$ 25.23M	$ 25.54M	$ 25.30M
Net Debt	$ -319.49M	$ -324.82M	$ -278.06M	$ -291.33M	$ -301.71M
Total Liabilities	$ 36.06M	$ 37.90M	$ 42.03M	$ 41.69M	$ 43.27M
Stockholders Equity	$ 344.35M	$ 348.95M	$ 299.51M	$ 311.26M	$ 320.74M
Cash Flow	-
Free Cash Flow	$ -10.42M	-	$ -15.63M	$ -14.20M	$ -13.97M
Operating Cash Flow	$ -9.90M	$ -11.71M	$ -15.05M	$ -13.91M	$ -11.91M
Investing Cash Flow	$ 11.12M	$ -61.45M	$ 17.87M	$ -8.74M	$ -1.60M
Financing Cash Flow	$ 831.00K	$ 56.61M	$ 528.00K	$ 1.58M	$ 191.00K

Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Income Statement >

Janux Therapeutics Inc Debt to Assets

Balance Sheet >

Janux Therapeutics Inc Cash Flow

Cash Flow >

Janux Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing